The MRC/BHF CoRE in Advanced Cardiac Therapies (REACT) unites academic, healthcare, industry and public partners to develop innovative DNA and RNA-based therapies to regenerate injured hearts and reverse established damage.

RNA molecule.

Heart failure affects almost one million people in the UK and more than 65 million people around the world, with heart attacks the main cause. No current treatment is able to regenerate the heart after a heart attack.

Our growing community brings together scientists and clinicians across academia and industry to discover new medicines based on the fundamental processes that drive heart failure and regulate cardiac regeneration.

We are developing advanced cardiac therapies: first-in-human DNA and RNA-based medicines to rebuild injured hearts and improve heart function.

Projects addressing our three research challenges will accelerate our ability to identify therapeutic targets, deliver them successfully to the heart, and translate treatments from bench to bedside within the next decade.

Heart icon

Target discovery

We are identifying, prioritising and validating therapeutic nucleic acids that will leverage endogenous reparative processes to generate new heart muscle, promote vessel formation and resolve fibrosis.
Heart icon

Cardiac delivery

We are developing cardiac-specific targeting mechanisms to administer therapeutic nucleic acids to the heart using innovative nanoformulations and viral vectors.
Heart icon

Clinical translation

We are building a pipeline to test and evaluate new medicines based on therapeutic nucleic acids and readying ourselves for a structured approach to clinical trials.
Scientist in lab coat pipetting at bench.

Our approach

We are building a network of leading researchers and a positive, collaborative environment across all of our partner organisations. 

This will provide a strong foundation for team science, training and career development, and open and engaged research.

Fluorescent microscope image of heart cells.

The concept behind our centre

Our Directors have written about the evolution of our centre in an open-access CardioPulse article for the European Society of Cardiology.

People working at tables in a cafe area.

Opportunities to get involved

REACT is a virtual centre across the UK and beyond. Our mission is deeply collaborative and there are a range of ways for you to work, learn and partner with our specialists.

Two people smiling at table in front of laptop.

Help us embed lived experience in our work

We want to work more with patients and communities with experience of heart attack and failure. We are committed to listening to the views of those who stand to benefit from our therapies and shaping research together.

Person holding smartphone.

Updates direct to your inbox

Our termly newsletter is the place for curated news, events and opportunities from people and projects across REACT.

At a glance

£1.68m
of REACT research funding has been awarded to new projects in our first twelve months.